Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$12.1000
-0.4100 (-3.2774%)
- Prev. close
- 12.5100
- Volume
- 97,538
- High
- 12.6000
- Capitalization
- 513.593M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€11.2300
-0.1600 (-1.4047%)
- Prev. close
- 11.3900
- Volume
- 33,835
- High
- 11.5400
- Capitalization
- 476.665M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier – Marion Levi
BTIG - Amanda Murphy
Citi - Robyn Karnauskas
Goldman Sachs - Salveen Richter
Jefferies – Biren Amin
Jones Trading - Soumit Roy
Ladenburg – Wangzhi Li
Nomura / Instinet – Christopher Marai
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
Portzamparc – Christophe Dombu
Suntrust Robinson – Peter Lawson
Wells Fargo – Jim Birchenough
William Blair – Raju Prasad
Cellectis contact information
Simon Harnest
Investor Relations USA
+1 646 385 9008
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89